Effect of Menstrugole on primary dysmenorrhea: a randomized clinical trial.
10.5468/ogs.2018.61.6.684
- Author:
Fatemeh SHOBEIRI
1
;
Sasan NAZARI
;
Saman NAZARI
;
Ensiyeh JENABI
;
Arezoo SHAYAN
Author Information
1. Mother and Child Care Research Center, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran.
- Publication Type:Clinical Trial ; Original Article
- Keywords:
Dysmenorrhea;
Adolescent;
Analgesics
- MeSH:
Adolescent;
Analgesics;
Dysmenorrhea*;
Female;
Health Personnel;
Humans;
Iran;
Menstrual Cycle;
Visual Analog Scale
- From:Obstetrics & Gynecology Science
2018;61(6):684-687
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Primary dysmenorrhea occurs in more than 50% of women of reproductive age. This survey evaluated the effects of Menstrugole on the alleviation of primary dysmenorrhea. METHODS: This study was performed in western Iran between August 15 and December 15, 2017, in female students with primary dysmenorrhea. The students were randomly divided into 2 groups and received placebo or a Menstrugole capsule for 3 days in each of 2 menstrual cycles. The visual analog scale was used to assess pain severity. The χ2 test, one-way analysis of variance, and the paired t-test were used for statistical evaluation. RESULTS: We compared the severity of pain between the 2 groups. There was a significant change in the mean pain score during the first (P < 0.001) and second months (P < 0.001) after the use of Menstrugole, compared with that in the placebo group. CONCLUSION: Menstrugole decreased pain severity in female students, and can be considered by health care providers for treatment of primary dysmenorrhea.
